Results     25-May-21
Announcements
Astrazeneca Pharma India standalone net profit rises 184.76% in the March 2021 quarter
Sales rise 7.88% to Rs 210.26 crore
Net profit of Astrazeneca Pharma India rose 184.76% to Rs 27.28 crore in the quarter ended March 2021 as against Rs 9.58 crore during the previous quarter ended March 2020. Sales rose 7.88% to Rs 210.26 crore in the quarter ended March 2021 as against Rs 194.90 crore during the previous quarter ended March 2020.

For the full year,net profit rose 29.19% to Rs 93.30 crore in the year ended March 2021 as against Rs 72.22 crore during the previous year ended March 2020. Sales declined 2.19% to Rs 813.56 crore in the year ended March 2021 as against Rs 831.81 crore during the previous year ended March 2020.

ParticularsQuarter EndedYear Ended
 Mar. 2021Mar. 2020% Var.Mar. 2021Mar. 2020% Var.
Sales210.26194.90 8 813.56831.81 -2
OPM %19.227.59 -16.6514.51 -
PBDT42.6817.89 139 147.22132.55 11
PBT36.8413.35 176 127.09113.97 12
NP27.289.58 185 93.3072.22 29

Previous News
  Board of Astrazeneca Pharma India recommends final dividend
 ( Corporate News - 28-May-24   09:52 )
  Astrazeneca Pharma India Ltd leads gainers in 'A' group
 ( Hot Pursuit - 27-May-22   12:00 )
  Astrazeneca Pharma India to discuss results
 ( Corporate News - 08-Aug-23   11:05 )
  Astrazeneca Pharma India standalone net profit declines 21.16% in the December 2020 quarter
 ( Results - Announcements 09-Feb-21   09:45 )
  AstraZeneca Pharma Q3 PAT falls 45% YoY to Rs 11 cr
 ( Hot Pursuit - 09-Feb-22   08:46 )
  Astrazeneca Pharma India standalone net profit declines 2.44% in the March 2020 quarter
 ( Results - Announcements 18-May-20   18:30 )
  AstraZeneca Pharma India terminates its distribution agreement with Abbott Healthcare
 ( Corporate News - 28-May-21   12:00 )
  Astrazeneca Pharma India standalone net profit declines 45.75% in the December 2021 quarter
 ( Results - Announcements 09-Feb-22   08:13 )
  Board of Astrazeneca Pharma India appoints director
 ( Corporate News - 15-Mar-19   10:02 )
  Board of Astrazeneca Pharma India recommends Final Dividend
 ( Corporate News - 27-May-22   10:25 )
  Astrazeneca Pharma slips as Sebi says exchanges to monitor delisting
 ( Hot Pursuit - 25-Jun-14   10:16 )
Other Stories
  Kronox Lab Sciences standalone net profit rises 140.98% in the March 2024 quarter
  29-Jun-24   07:31
  Performance Chemiserve standalone net profit rises 6062.22% in the March 2024 quarter
  27-Jun-24   07:24
  Sundew Properties standalone net profit rises 119.15% in the March 2024 quarter
  27-Jun-24   07:24
  IKF Home Finance standalone net profit rises 42.15% in the March 2024 quarter
  27-Jun-24   07:24
  Delhi Transco standalone net profit rises 1.08% in the March 2024 quarter
  27-Jun-24   07:24
  Profectus Capital Pvt standalone net profit rises 12.12% in the March 2024 quarter
  27-Jun-24   07:24
  Shrem Infra Invest Pvt consolidated net profit rises 290.12% in the March 2024 quarter
  27-Jun-24   07:24
  Bharat Ekansh reports consolidated net loss of Rs 0.01 crore in the March 2024 quarter
  27-Jun-24   07:24
  Patel KNR Heavy Infrastructures reports standalone net loss of Rs 2.71 crore in the March 2024 quarter
  27-Jun-24   07:24
  Supreme Infrastructure India reports consolidated net loss of Rs 326.26 crore in the March 2024 quarter
  26-Jun-24   07:29
Back Top